AbbottUS0028241000ABTABT
Financials
Market Cap
$184.43B5Y beta
0.75EPS (TTM)
$3.22Free Float
1.73BP/E ratio (TTM)
33.01Revenue (TTM)
$40.33BEBITDA (TTM)
$9.59BPricing
Analyst Ratings
The price target is $126.37 and the stock is covered by 22 analysts.
Buy
15
Hold
7
Sell
0
Information
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.